Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System INS Model 5101 (R20) for the Indication of Fecal Incontinence (FI)

NCT07499258 is registered in ClinicalTrials.gov with Axonics, Inc. as lead sponsor.

NCT NCT07499258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07499258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System INS Model 5101 (R20) for the Indication of Fecal Incontinence (FI)
Lead sponsor
Axonics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 2, 2026
Completion date
June 30, 2028
Enrollment
55 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence